Global Maternal Blood Test Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 3.81 Billion |
 Market Size (Forecast Year) |
USD 10.12 Billion |
 CAGR |
% |
| Major Markets Players |
>全球孕产妇血液检测市场，按类型（妊娠第一期联合筛查、妊娠第二期孕产妇血清筛查）、检测条件（爱德华氏综合症、帕陶氏综合症、唐氏综合症、神经管缺陷）、最终用户（诊断实验室、医院）划分 - 行业趋势和预测到 2030 年。
母体血液检测市场分析及规模
推动母体血液检测市场增长的主要因素之一是全球 NIPT 报销情况的持续改善。染色体异常发病率的增加，加上产品在新应用中的使用率不断提高，推动了市场的增长。人们对非侵入性技术的兴趣日益浓厚，而非侵入性方法，以及旨在提高 NIPT 意识的计划的增多，都对市场产生了影响。
Data Bridge Market Research 分析，2022 年母体血液检测市场规模为 38.07 亿美元，预计到 2030 年将达到 101.2 亿美元，2023 年至 2030 年预测期内的复合年增长率为 13.00%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
母体血液检测市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
类型（联合孕早期筛查、孕中期母体血清筛查）、检测条件（爱德华氏综合症、帕陶氏综合症、唐氏综合症、神经管缺陷）、最终用户（诊断实验室、医院） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
CENTOGENE NV（德国）、SEQUENOM（美国）、Natera, Inc.（美国）、LifeLabs Genetics（加拿大）、Sema4 OpCo, Inc.（美国）、Invitae Corporation（美国）、Illumina, Inc.（美国）、Thermo Fisher Scientific Inc.（美国）、通用电气（美国）、PerkinElmer Inc.（美国）、安捷伦科技公司（美国）、华大基因（中国）、F. Hoffmann-La Roche Ltd（瑞士）、YOURGENE HEALTH（英国）、Eurofins Scientific（卢森堡）、EKF Diagnostics（德国） |
|
市场机会 |
|
Market Definition
A maternal blood test is a type of prenatal screening test that determines the likelihood that a chromosome disorder will impact a pregnancy or certain behavioural issues will impact a pregnancy. The primary goal of the test is to ensure that the baby does not have any chromosomal abnormalities such as Down syndrome. These tests are known to be capable of providing more information about pregnancy health.
Global Maternal Blood Test Market Dynamics
Drivers
- Rising use of maternal blood tests
Maternal blood tests can detect and diagnose chromosomal rearrangements, X-linked diseases, and aid in the reduction of spontaneous abortions, increased implantation rates, the prevention of trisomic offspring, and the avoidance of the risk of transmitting single gene disorders. However, PGS and PGD results are not 100% accurate, and if necessary, diagnostic tests such as amniocentesis and CVS must be performed after pregnancy to confirm the positive PGS/PGD results. In the United States alone, more than 63,000 babies were born through IVF in 2013, an increase of 2,000 births from 2012. These are the certain test that help the market to grow.
Opportunities
- Introduction of NIPTs
The introduction of NIPTs using cell-free foetal DNA (cffDNA) in 2011 was the most significant advancement in the field of prenatal screening. Obstetricians and patients who are put off by ultrasound screening's 10% to 15% false positive rate and maternal serum test's 5% false positive rate are eagerly embracing NIPTs that claim to have only a 5% false positive rate. In just four years, molecular genetics companies have successfully developed eight different types of kits for detecting genetic abnormalities in foetus. These products have gradually marginalized maternal serum tests, and maternal serum tests are expected to become obsolete within the next decade.
Restraints/Challenges
- Lack of skilled professionals
Lack of skilled and trained professionals, strict regulatory guidelines and ethical stumbling blocks limits the market's growth during the forecast period.
This maternal blood test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the maternal blood test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Maternal Blood Test Market Scope
母体血液检测市场根据类型、检测条件和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- 孕早期综合筛查
- 妊娠中期孕妇血清筛查
测试条件
- 爱德华氏症候群
- 帕陶综合征
- 唐氏综合症
- 神经管缺陷
终端用户
- 诊断实验室
- 医院
母体血液检测市场区域分析/见解
对母体血液检测市场进行了分析，并按国家、类型、检测条件和最终用户提供了市场规模洞察和趋势。
母血检测市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于北美地区广泛采用先进技术，因此其在母体血液检测市场占据主导地位。
由于医疗保健基础设施的发展以及该地区宣传计划和会议的增多，预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
母体血液检测市场还为您提供了每个国家/地区资本设备医疗保健支出增长、母体血液检测市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对母体血液检测市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。
竞争格局和孕妇血液检测市场份额分析
母体血液检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对母体血液检测市场的关注有关。
母体血液检测市场的一些主要参与者包括：
- CENTOGENE NV（德国）
- SEQUENOM（美国）
- Natera, Inc.（美国）
- LifeLabs Genetics（加拿大）
- Sema4 OpCo, Inc.（美国）
- Invitae Corporation（美国）
- Illumina 公司（美国）
- 赛默飞世尔科技公司（美国）
- 通用电气（美国）
- PerkinElmer Inc.（美国）
- 安捷伦科技公司（美国）
- 华大基因（中国）
- F. Hoffmann-La Roche Ltd（瑞士）
- YOURGENE HEALTH（英国）
- Eurofins Scientific（卢森堡）
- EKF 诊断（德国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
